Atish D Choudhury

27PUBLICATIONS
186CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Nov 18, 2025
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer.

Autumn Gagnon, Caiwei Zhong, Wanling Xie

|Oct 28, 2025
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer.

Autumn Gagnon, Caiwei Zhong, Wanling Xie

|Apr 01, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes.

Marina N Sharifi, Jamie M Sperger, Amy K Taylor

|Mar 19, 2025
Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience.

Meryam Losee, Michael Kavanaugh, Mofei Liu

|Feb 06, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.

Marina N Sharifi, Jamie M Sperger, Amy K Taylor

Pageof 5

Frequent Collaborators

5 joint publications

Christopher Sweeney

4 joint publications

Rana R McKay

4 joint publications

Xiao X Wei

4 joint publications

Bradley McGregor